FDA
approval
· 2024-03-15
FDA Approved: EDURANT PED — Original Application (Janssen Products, LP)
Summary
FDA approved EDURANT PED (rilpivirine hydrochloride) for HIV-1 infection in pediatric patients, establishing the original pediatric indication for this therapy.…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EDURANT PED (RILPIVIRINE HYDROCHLORIDE)